Does screening HIV-positive individuals in uganda for major depressive disorder improve case detection rates and antidepressant prescription?

AIDS and Behavior

Volumn 17, Issue 8, 2013, Pages 2802-2807

  Akena, Dickens ^a,b   Stein, Dan J ^a   Joska, John ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MAKERERE UNIVERSITY   (Uganda)

Author keywords

Antidepressants; HIV AIDS; Major depression; Screening outcomes; Uganda

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR DEPRESSION; MALE; MASS SCREENING; MEDICATION COMPLIANCE; MIDDLE AGED; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; STATISTICS; UGANDA;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; DRUG PRESCRIPTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MEDICATION ADHERENCE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PRIMARY HEALTH CARE; UGANDA;

EID: 84885434275     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-012-0383-y     Document Type: Article

References (43)

1. Olatunji BO, Mimiaga MJ, O'Cleirigh C, Safren SA. Review of treatment studies of depression in HIV. Top HIV Med. 2006;14(3):112-24.
2. Nakimuli-Mpungu E, Mutamba B, Nshemerirwe S, Kiwuwa MS, Musisi S, Munyaneza G. Depression, alcohol abuse, and disclosure of HIV serostatus among rural HIV-positive individuals in western Uganda. Neurobehav HIV Med. 2011;3:19-25.
3. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158:725-30.
4. Morrison MF, Petitto JM, Ten Have T, Gettes DR, Chiappini MS, Weber AL, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002;159:789-96.
5. Reilly T, Smith L, Woodruff SI, Cade J. Predictors of death and survival duration among a sample of persons living with HIV/AIDS. Soc Work Health Care. 2010;49:783-98.
6. Leserman J, Petitto JM, Golden RN, Gaynes BN, Gu H, Perkins DO, et al. Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry. 2000;157:1221-8.
7. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466-74.
8. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270:2568-73.
9. Cook JA, Grey D, Burke J, Cohen MH, Gurtman AC, Richardson JL, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94:1133-40.
10. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45:394-402.
11. Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10:53-61.
12. Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009;59:e51-60.
13. Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384-90.
14. Rabkin JG, Wagner GJ, Rabkin R. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, Placebo-controlled trial. Am J Psychiatry. 1999;156:101-7.
15. Bass J, Neugebauer R, Clougherty KF, Verdeli H, Wickramaratne P, Ndogoni L, et al. Group interpersonal psychotherapy for depression in rural Uganda: 6-month outcomes: randomised controlled trial. Br J Psychiatry. 2006;188:567-73.
16. Cruess DG, Douglas SD, Petitto JM, Ten Have T, Gettes D, Dubé B, et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry. 2005;162:2125-30.
17. Tylee A. Depression in the community: physician and patient perspective. J Clin Psychiatry. 1999;60(Suppl 7):12-6.
18. Baik S-Y, Bowers BJ, Oakley LD, Susman JL. The recognition of depression:the primary care clinician's perspective. Ann Fam Med. 2005;3:31-7. doi: 10.1370/afm.239.
19. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1997;12:679-85.
20. Kigozi F, Ssebunnya J, Kizza D, Cooper S, Ndyanabangi S. The mental health and poverty project. An overview of Uganda's mental health care system: results from an assessment using the world health organization's assessment instrument for mental health systems (WHOAIMS). Int J Ment Health Syst. 2010;4:1.
21. Kigozi NF, Ssebunnya J. Integration of mental health into primary health care in Uganda: opportunities and challenges. Ment Health Fam Med. 2009;6:37-42.
22. Collins PY, Holmand AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS Behav. 2006;20(12):1571-82.
23. United States Preventive Services Task Force Clinical Guidelines. Screening for depression: recommendations and rationale. In: Force USPST, editor. Ann Intern Med. 2002;136(10):760-4.
24. National Institute of Clinical Excellence. Depression: management of depression in primary and secondary care. London;2004.
25. Hickie BI, Davenport TA, Ricci CS. Screening for depression in general practice and related medical settings. Med J Aust. 2002;177:S111-6.
26. Valenstein M, Dalack G, Blow F, Figueoroa S, Standiford C, Douglass A. Screening for a psychiatric illness with a combined screening and diagnostic instrument. J Gen Intern Med. 1997;12:679-85.
27. Christensen KS, Tofta T, Frostholma L, Ørnbøla E, Finka P, Olesen F. Screening for common mental disorders: who will benefit? Results from a randomised clinical trial. Fam Pract. 2005;22:428-34.
28. Magruder-Habib K, Zung WW, Feussner JR. Improving physicians' recognition and treatment of depression in general medical care: results from a randomized clinical trial. Med Care. 1990;28:239-50.
29. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans CT, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence. Ann Intern Med. 2002;136(10):765-76.
30. Badamgarav E, Weingarten SR, Henning JM, Knight K, Hasselblad V, Gano A, et al. Effectiveness of disease management programs in depression: a systematic review. Am J Psychiatry. 2003;160:2080-90.
31. O'Connor EA, Whitlock EP, Gaynes B, Beil TL. Screening for depression in adults and older adults in primary care: an updated systematic review. Rockville: Agency for Healthcare Research and Quality; 2009.
32. Gilbodyl S, Sheldon T, House A. Screening and case-finding instruments for depression:a meta-analysis. CMAJ. 2008;178(8):997-1003.
33. Meijer A, Roseman M, Milette K, Coyne JC, Stefanek ME, Ziegelstein RC, et al. Depression screening and patient outcomes in cancer: a systematic review. PLoS ONE. 2011;6(11):e27181. doi: 10.1371/journal.pone.0027181.
34. Kroenke K, Spitzer RL, WIlliams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(8):606-13. doi: 10.1046/j.525-497.2001.016009606.x.
35. Radloff LS. Center for epidemiologic studies depression scale (CESD). In: center for epidemiologic studies NIMH. Washington: West Publishing Company; 1977.
36. Kessler C, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959-76.
37. Sheehan DV, Lecrubier Y, Sheehan KH. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview. J Clin Psychiatry. 1998;59:22-3.
38. STATA Inventor. STATA, statistics/data analysis. College Station: STATA Inventor; 2011.
39. Ski CF, Page K, Thompson DR, Cummins RA, Salzberg M, Worrall-Carter L. Clinical outcomes associated with screening and referral for depression in an acute cardiac ward. J Clin Nurs. 2011;. doi: 10.1111/j.365-2702.011.03934.x.
40. Treisman G, Angelino A. Interrelation between psychiatric disorders and the prevention and treatment of HIV infection. Clin Infect Dis. 2007;45:S313-7.
41. Sherbourne CD, Hays RD, Fleishman JA, Vitiello B, Magruder KM, Bing EG, et al. Impact of psychiatric conditions on health-related quality of life in persons with HIV infection. Am J Psychiatry. 2000;157:248-54.
42. Evans DL, Ten Have TR, Douglas SD, Gettes DR, Morrison M, Chiappini MS, et al. Association of depression with viral load, CD8T lymphocytes, and natural killer cellsin women with HIV infection. Am J Psychiatry. 2002;159:1752-9.
43. Pignone MP, Gaynes BN, Rushton JL, Burchell CM, Orleans TC, Mulrow CD, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-76.